1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Tobemstomig: new trials by email Literature Review of Tobemstomig trials Research Report on Tobemstomig
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma Atezolizumab, Bevacizumab, Tiragolumab - Carcinoma, Hepatocellular | Phase 1 / Phase 2 | Terminated | Hoffmann-La Roche | 62 | 2023-12-05 | 2026-09-15 |
Austria (1) · France (1) · Germany (1) · Spain (1) · United Kingdom (1) · United States (1)